Transdermal therapeutical system comprising physostigmine as active component and process for the production thereof

• Main Authors: HILLE THOMAS DR, HOFFMANN HANS-RAINER DR, KNOCH AXEL DR, SCHNEIDER GERHARD DR, STANISLAUS FRITZ DR, HUBER HANS-JOACHIM DR
• Format: Patent
• Language: English
• Published: 06.09.1995
• Edition: 5
• Subjects: CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES; DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; HUMAN NECESSITIES; HYGIENE; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES; MEDICAL OR VETERINARY SCIENCE; METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

The invention relates to a transdermal therapeutic system for the administration of physostigmine onto the skin, composed of a backing layer which is impermeable to the active ingredient, of an active ingredient depot having at least one auxiliary with supportive and distributive function in the form of a sheet-like textile material, of a matrix surrounding the latter on all sides and, where appropriate, of a protective layer which can be detached again, the matrix of which contains 10 - 90 % by weight of polymeric material selected from the group consisting of acrylate- and/or methacrylate-based polymers and esters of hydrogenated rosin, 0 - 30 % by weight of plasticisers based on hydrocarbons and/or esters, and the active ingredient depot contains 15 to 85 % by weight of a 0.1 to 70 % by weight physostigmine solution immediately after manufacture.